Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Image Gallery: Primary cutaneous Rosai-Dorfman disease.

Gupta GK, Pittaluga S, Cowen EW.

Br J Dermatol. 2019 Jun 25. doi: 10.1111/bjd.17999. [Epub ahead of print] No abstract available.

PMID:
31240695
2.

Trichomegaly induced by topical tacrolimus for the treatment of periorbital vitiligo: A brief report of a new adverse effect.

Molés-Poveda P, Cowen EW.

Pediatr Dermatol. 2019 Jul;36(4):e95-e96. doi: 10.1111/pde.13825. Epub 2019 May 9.

PMID:
31070265
3.

Birt-Hogg-Dubé syndrome initially diagnosed as tuberous sclerosis complex.

Pithadia DJ, Treichel AM, Lee CR, Cowen EW, Linehan WM, Moss J, Darling TN.

JAAD Case Rep. 2019 Apr 5;5(4):368-371. doi: 10.1016/j.jdcr.2019.02.009. eCollection 2019 Apr. No abstract available.

4.

Decoding Skin Involvement in Chronic Graft-vs-Host Disease.

Cowen EW.

JAMA Dermatol. 2019 Apr 17. doi: 10.1001/jamadermatol.2019.0354. [Epub ahead of print] No abstract available.

PMID:
30994870
5.

Recurrent fevers, progressive lipodystrophy, and annular plaques in a child.

Cardis MA, Montealegre Sanchez GA, Goldbach-Mansky R, Richard Lee CC, Cowen EW.

J Am Acad Dermatol. 2019 Jan;80(1):291-295. doi: 10.1016/j.jaad.2018.08.043. Epub 2018 Sep 8.

PMID:
30205133
6.

Understanding the evolving phenotype of vascular complications in telomere biology disorders.

Higgs C, Crow YJ, Adams DM, Chang E, Hayes D Jr, Herbig U, Huang JN, Himes R, Jajoo K, Johnson FB, Reynolds SD, Yonekawa Y, Armanios M, Boulad F, DiNardo CD, Dufour C, Goldman FD, Khan S, Kratz C, Myers KC, Raghu G, Alter BP, Aubert G, Bhala S, Cowen EW, Dror Y, El-Youssef M, Friedman B, Giri N, Helms Guba L, Khincha PP, Lin TF, Longhurst H, McReynolds LJ, Nelson A, Olson T, Pariser A, Perona R, Sasa G, Schratz K, Simonetto DA, Townsley D, Walsh M, Stevens K, Agarwal S, Bertuch AA, Savage SA; Clinical Care Consortium for Telomere-associated Ailments (CCCTAA).

Angiogenesis. 2019 Feb;22(1):95-102. doi: 10.1007/s10456-018-9640-7. Epub 2018 Aug 25.

PMID:
30168024
7.

Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.

Jha S, Fratzl-Zelman N, Roschger P, Papadakis GZ, Cowen EW, Kang H, Lehky TJ, Alter K, Deng Z, Ivovic A, Flynn L, Reynolds JC, Dasgupta A, Miettinen M, Lange E, Katz J, Klaushofer K, Marini JC, Siegel RM, Bhattacharyya T.

J Bone Miner Res. 2019 Jan;34(1):145-156. doi: 10.1002/jbmr.3577. Epub 2018 Sep 14.

PMID:
30138550
8.

Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.

Kerep AZ, Broome J, Pirsl F, Curtis LM, Steinberg SM, Mitchell SA, Cowen EW, Pichard DC, Joe GO, Comis LE, Mays JW, Datiles MB 3rd, Stratton P, Zolton J, Berger A, Hendricks J, Kenyon M, Baruffaldi J, Titarenko I, Pulanic D, Baird K, Fowler DH, Gress RE, Pavletic SZ.

Bone Marrow Transplant. 2019 Jan;54(1):76-84. doi: 10.1038/s41409-018-0224-3. Epub 2018 Aug 8.

PMID:
30089900
9.

Immunotherapy and Skin Side Effects.

Anadkat MJ, Cowen EW.

JAMA Dermatol. 2018 Jun 1;154(6):744. doi: 10.1001/jamadermatol.2018.0269. No abstract available.

PMID:
29898228
10.

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.

J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11.

11.

Somatic activating mutations in MAP2K1 cause melorheostosis.

Kang H, Jha S, Deng Z, Fratzl-Zelman N, Cabral WA, Ivovic A, Meylan F, Hanson EP, Lange E, Katz J, Roschger P, Klaushofer K, Cowen EW, Siegel RM, Marini JC, Bhattacharyya T.

Nat Commun. 2018 Apr 11;9(1):1390. doi: 10.1038/s41467-018-03720-z.

12.

Tumor-induced osteomalacia in association with PTEN-negative Cowden syndrome.

Berglund JA, Gafni RI, Wodajo F, Cowen EW, El-Maouche D, Chang R, Chen CC, Guthrie LC, Molinolo AA, Collins MT.

Osteoporos Int. 2018 Apr;29(4):993-997. doi: 10.1007/s00198-017-4372-x. Epub 2018 Jan 29.

PMID:
29380000
13.

Beyond the triad: Inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita.

Ward SC, Savage SA, Giri N, Alter BP, Rosenberg PS, Pichard DC, Cowen EW.

J Am Acad Dermatol. 2018 Apr;78(4):804-806. doi: 10.1016/j.jaad.2017.10.017. Epub 2017 Oct 16. No abstract available.

14.

Progressive reticulate skin pigmentation and anonychia in a patient with bone marrow failure.

Ward SC, Savage SA, Giri N, Alter BP, Cowen EW.

J Am Acad Dermatol. 2017 Dec;77(6):1194-1198. doi: 10.1016/j.jaad.2017.07.018. Epub 2017 Oct 21.

15.

Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients.

Curtis LM, Pirsl F, Steinberg SM, Mitchell SA, Baird K, Cowen EW, Mays J, Buxbaum NP, Pichard DC, Im A, Avila D, Taylor T, Fowler DH, Gress RE, Pavletic SZ.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1980-1988. doi: 10.1016/j.bbmt.2017.08.005. Epub 2017 Aug 7.

16.

Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft-versus-host disease.

Goklemez S, Pirsl F, Curtis LM, Steinberg SM, Cowen EW, Mays JW, Kenyon M, Baruffaldi J, Hakim FT, Pavletic SZ.

Am J Hematol. 2017 Aug;92(8):E162-E164. doi: 10.1002/ajh.24768. Epub 2017 Jun 1. No abstract available.

17.

Diffuse atrophic papules and plaques, intermittent abdominal pain, paresthesias, and cardiac abnormalities in a 55-year-old woman.

Oliver B, Boehm M, Rosing DR, Shapiro LS, Dempsey DT, Merkel PA, Lee CR, Cowen EW.

J Am Acad Dermatol. 2016 Dec;75(6):1274-1277. doi: 10.1016/j.jaad.2016.09.015. Epub 2016 Oct 4.

18.

Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.

Hakim FT, Memon S, Jin P, Imanguli MM, Wang H, Rehman N, Yan XY, Rose J, Mays JW, Dhamala S, Kapoor V, Telford W, Dickinson J, Davis S, Halverson D, Naik HB, Baird K, Fowler D, Stroncek D, Cowen EW, Pavletic SZ, Gress RE.

J Immunol. 2016 Nov 1;197(9):3490-3503. Epub 2016 Sep 30.

19.

Early-onset stroke, polyarteritis nodosa (PAN), and livedo racemosa.

Pichard DC, Ombrello AK, Hoffmann P, Stone DL, Cowen EW.

J Am Acad Dermatol. 2016 Aug;75(2):449-53. doi: 10.1016/j.jaad.2016.01.057.

20.

Erratum to "Salivary Gland Involvement in Chronic Graft-versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation" [Biol Blood Marrow Transplant 16:1362-1369].

Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, Datiles MB, Hakim FT, Kleiner DE, Krumlauf MC, Pavletic SZ.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1147. doi: 10.1016/j.bbmt.2015.09.026. Epub 2015 Oct 9. No abstract available.

21.

Medallion-Like Dermal Dendrocytic Hamartoma, Dermatofibrosarcoma Protuberans, and Adenosine Deaminase-Deficient Severe Combined Immunodeficiency.

Cowen EW, Pichard DC, Garabedian E, Miettinen M.

Pediatr Dermatol. 2016 May;33(3):359-60. doi: 10.1111/pde.12847. No abstract available.

22.

Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.

Cohen JI, Dropulic L, Hsu AP, Zerbe CS, Krogmann T, Dowdell K, Hornung RL, Lovell J, Hardy N, Hickstein D, Cowen EW, Calvo KR, Pittaluga S, Holland SM.

Clin Infect Dis. 2016 Jul 1;63(1):41-7. doi: 10.1093/cid/ciw160. Epub 2016 May 11.

23.

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia.

Bitar C, Farooqui MZ, Valdez J, Saba NS, Soto S, Bray A, Marti G, Wiestner A, Cowen EW.

JAMA Dermatol. 2016 Jun 1;152(6):698-701. doi: 10.1001/jamadermatol.2016.0225.

24.

Graft-vs-Host Disease.

Cowen EW.

JAMA Dermatol. 2016 Mar;152(3):356. doi: 10.1001/jamadermatol.2015.5659. No abstract available.

PMID:
26964058
25.

Cutaneous adverse events in multiple sclerosis patients treated with daclizumab.

Cortese I, Ohayon J, Fenton K, Lee CC, Raffeld M, Cowen EW, DiGiovanna JJ, Bielekova B.

Neurology. 2016 Mar 1;86(9):847-55. doi: 10.1212/WNL.0000000000002417. Epub 2016 Feb 3.

26.

Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy.

Chia J, Eroglu FK, Özen S, Orhan D, Montealegre-Sanchez G, de Jesus AA, Goldbach-Mansky R, Cowen EW.

J Am Acad Dermatol. 2016 Jan;74(1):186-9. doi: 10.1016/j.jaad.2015.10.007. Epub 2015 Nov 14.

27.

Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus.

Nathan N, Wang JA, Li S, Cowen EW, Haughey M, Moss J, Darling TN.

J Am Acad Dermatol. 2015 Nov;73(5):802-8. doi: 10.1016/j.jaad.2015.07.018. Epub 2015 Sep 11.

28.

Primary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestations.

Pichard DC, Freeman AF, Cowen EW.

J Am Acad Dermatol. 2015 Sep;73(3):367-81; quiz 381-2. doi: 10.1016/j.jaad.2015.01.055. Review.

29.

Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

Pichard DC, Freeman AF, Cowen EW.

J Am Acad Dermatol. 2015 Sep;73(3):355-64; quiz 365-6. doi: 10.1016/j.jaad.2015.01.054. Review.

30.

Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.

Naik HB, Steinberg SM, Middelton LA, Hewitt SM, Zuo RC, Linehan WM, Kong HH, Cowen EW.

JAMA Dermatol. 2015 Oct;151(10):1096-102. doi: 10.1001/jamadermatol.2015.1793.

PMID:
26244563
31.

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.

Curtis LM, Datiles MB 3rd, Steinberg SM, Mitchell SA, Bishop RJ, Cowen EW, Mays J, McCarty JM, Kuzmina Z, Pirsl F, Fowler DH, Gress RE, Pavletic SZ.

Haematologica. 2015 Sep;100(9):1228-36. doi: 10.3324/haematol.2015.124131. Epub 2015 Jun 18.

32.

Comedonal and Cystic Fibrofolliculomas in Birt-Hogg-Dube Syndrome.

Aivaz O, Berkman S, Middelton L, Linehan WM, DiGiovanna JJ, Cowen EW.

JAMA Dermatol. 2015 Jul;151(7):770-4. doi: 10.1001/jamadermatol.2015.0215.

PMID:
25970555
33.

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.

Bates SE, Eisch R, Ling A, Rosing D, Turner M, Pittaluga S, Prince HM, Kirschbaum MH, Allen SL, Zain J, Geskin LJ, Joske D, Popplewell L, Cowen EW, Jaffe ES, Nichols J, Kennedy S, Steinberg SM, Liewehr DJ, Showe LC, Steakley C, Wright J, Fojo T, Litman T, Piekarz RL.

Br J Haematol. 2015 Jul;170(1):96-109. doi: 10.1111/bjh.13400. Epub 2015 Apr 19.

34.

Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.

Baird K, Comis LE, Joe GO, Steinberg SM, Hakim FT, Rose JJ, Mitchell SA, Pavletic SZ, Figg WD, Yao L, Flanders KC, Takebe N, Sarantopoulos S, Booher S, Cowen EW.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1083-90. doi: 10.1016/j.bbmt.2015.03.006. Epub 2015 Mar 12.

35.

Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations.

Aderibigbe OM, Priel DL, Lee CC, Ombrello MJ, Prajapati VH, Liang MG, Lyons JJ, Kuhns DB, Cowen EW, Milner JD.

JAMA Dermatol. 2015 Jun;151(6):627-34. doi: 10.1001/jamadermatol.2014.5641.

36.

Oral disease profiles in chronic graft versus host disease.

Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Cowen EW, Naik H, Datiles M, Stratton P, Gress RE, Pavletic SZ.

J Dent Res. 2015 Apr;94(4):547-54. doi: 10.1177/0022034515570942. Epub 2015 Mar 4.

37.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME.

Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.

38.

Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literature.

Massey PR, Okman JS, Wilkerson J, Cowen EW.

Support Care Cancer. 2015 Jun;23(6):1827-35. doi: 10.1007/s00520-014-2520-9. Epub 2014 Dec 5. Review.

39.

Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

Zuo RC, Apolo AB, DiGiovanna JJ, Parnes HL, Keen CM, Nanda S, Dahut WL, Cowen EW.

JAMA Dermatol. 2015 Feb;151(2):170-7. doi: 10.1001/jamadermatol.2014.2734.

PMID:
25427282
40.

Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.

Kuzmina Z, Gounden V, Curtis L, Avila D, Rnp TT, Baruffaldi J, Cowen EW, Naik HB, Hasni SA, Mays JW, Mitchell S, Baird K, Steinberg SM, Pavletic SZ.

Am J Hematol. 2015 Feb;90(2):114-9. doi: 10.1002/ajh.23885. Epub 2014 Nov 24.

41.

Malignant melanoma masquerading as an angiofibroma in a patient with MEN-1.

Brown GT, Cowen EW, Lee CC.

JAMA Dermatol. 2015 Jan;151(1):105-6. doi: 10.1001/jamadermatol.2014.2186. No abstract available.

PMID:
25317507
42.

Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease.

Zuo RC, Naik HB, Steinberg SM, Baird K, Mitchell SA, Kuzmina Z, Pavletic SZ, Cowen EW.

JAMA Dermatol. 2015 Jan;151(1):23-32. doi: 10.1001/jamadermatol.2014.1550.

PMID:
25207994
43.

Trigeminal trophic syndrome after stroke.

Pichard DC, Cowen EW.

Mayo Clin Proc. 2014 Sep;89(9):e87-8. doi: 10.1016/j.mayocp.2013.10.038. No abstract available.

44.

NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.

Curtis LM, Grkovic L, Mitchell SA, Steinberg SM, Cowen EW, Datiles MB, Mays J, Bassim C, Joe G, Comis LE, Berger A, Avila D, Taylor T, Pulanic D, Cole K, Baruffaldi J, Fowler DH, Gress RE, Pavletic SZ.

Bone Marrow Transplant. 2014 Dec;49(12):1513-20. doi: 10.1038/bmt.2014.188. Epub 2014 Aug 25.

PMID:
25153693
45.

Palmoplantar pustules and osteoarticular pain in a 42-year-old woman.

Zuo RC, Schwartz DM, Lee CC, Anadkat MJ, Cowen EW, Naik HB.

J Am Acad Dermatol. 2015 Mar;72(3):550-3. doi: 10.1016/j.jaad.2014.07.014. Epub 2014 Aug 12.

46.

New facial papules in a 66-year-old woman with bladder cancer.

Nakrani RN, Ghosh A, Richard Lee CC, Agarwal PK, Apolo AB, Cowen EW.

J Am Acad Dermatol. 2014 Dec;71(6):1250-5. doi: 10.1016/j.jaad.2014.07.012. Epub 2014 Aug 7. No abstract available.

47.

Activated STING in a vascular and pulmonary syndrome.

Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Sanchez GAM, Tenbrock K, Wittkowski H, Jones OY, Kuehn HS, Lee CR, DiMattia MA, Cowen EW, Gonzalez B, Palmer I, DiGiovanna JJ, Biancotto A, Kim H, Tsai WL, Trier AM, Huang Y, Stone DL, Hill S, Kim HJ, St Hilaire C, Gurprasad S, Plass N, Chapelle D, Horkayne-Szakaly I, Foell D, Barysenka A, Candotti F, Holland SM, Hughes JD, Mehmet H, Issekutz AC, Raffeld M, McElwee J, Fontana JR, Minniti CP, Moir S, Kastner DL, Gadina M, Steven AC, Wingfield PT, Brooks SR, Rosenzweig SD, Fleisher TA, Deng Z, Boehm M, Paller AS, Goldbach-Mansky R.

N Engl J Med. 2014 Aug 7;371(6):507-518. doi: 10.1056/NEJMoa1312625. Epub 2014 Jul 16.

48.

Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements.

Teng JM, Cowen EW, Wataya-Kaneda M, Gosnell ES, Witman PM, Hebert AA, Mlynarczyk G, Soltani K, Darling TN.

JAMA Dermatol. 2014 Oct;150(10):1095-101. doi: 10.1001/jamadermatol.2014.938.

PMID:
25029267
49.

Malnutrition in patients with chronic GVHD.

Bassim CW, Fassil H, Dobbin M, Steinberg SM, Baird K, Cole K, Joe G, Comis LE, Mitchell SA, Grkovic L, Edwards D, Mays JW, Cowen EW, Pulanic D, Williams KM, Gress RE, Pavletic SZ.

Bone Marrow Transplant. 2014 Oct;49(10):1300-6. doi: 10.1038/bmt.2014.145. Epub 2014 Jul 14.

50.

Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.

Kaffenberger BH, Zuo RC, Gru A, Plotner AN, Sweeney SA, Devine SM, Hymes SR, Cowen EW.

J Am Acad Dermatol. 2014 Oct;71(4):745-53. doi: 10.1016/j.jaad.2014.05.034. Epub 2014 Jul 1.

Supplemental Content

Loading ...
Support Center